Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 15 studies | 24% ± 8% | |
peripheral blood | 13 studies | 25% ± 7% | |
brain | 8 studies | 27% ± 9% | |
intestine | 7 studies | 24% ± 11% | |
kidney | 5 studies | 23% ± 5% | |
bone marrow | 5 studies | 20% ± 5% | |
eye | 5 studies | 21% ± 8% | |
lymph node | 5 studies | 24% ± 15% | |
liver | 4 studies | 21% ± 5% | |
pancreas | 3 studies | 49% ± 13% | |
placenta | 3 studies | 29% ± 7% | |
uterus | 3 studies | 29% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 100% | 9078.55 | 328 / 328 | 100% | 152.80 | 178 / 178 |
stomach | 100% | 8405.82 | 359 / 359 | 100% | 120.64 | 285 / 286 |
lung | 100% | 11459.84 | 578 / 578 | 99% | 153.02 | 1149 / 1155 |
esophagus | 100% | 8071.38 | 1445 / 1445 | 99% | 88.74 | 182 / 183 |
prostate | 100% | 8825.73 | 245 / 245 | 99% | 184.98 | 499 / 502 |
skin | 100% | 10901.31 | 1809 / 1809 | 99% | 206.13 | 469 / 472 |
breast | 100% | 11042.39 | 459 / 459 | 99% | 154.59 | 1108 / 1118 |
ovary | 100% | 10934.93 | 180 / 180 | 99% | 80.14 | 426 / 430 |
thymus | 100% | 10838.03 | 653 / 653 | 99% | 150.74 | 599 / 605 |
kidney | 100% | 8319.39 | 89 / 89 | 99% | 159.58 | 891 / 901 |
bladder | 100% | 9164.24 | 21 / 21 | 99% | 131.79 | 498 / 504 |
uterus | 100% | 9560.28 | 170 / 170 | 99% | 140.58 | 453 / 459 |
intestine | 100% | 9433.95 | 966 / 966 | 99% | 124.03 | 520 / 527 |
liver | 100% | 7884.37 | 226 / 226 | 99% | 144.48 | 400 / 406 |
brain | 97% | 4484.59 | 2565 / 2642 | 100% | 199.41 | 704 / 705 |
adrenal gland | 100% | 8441.71 | 258 / 258 | 96% | 156.92 | 220 / 230 |
adipose | 100% | 10929.96 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 11471.44 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 159.97 | 80 / 80 |
spleen | 100% | 10841.81 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 139.31 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 25.45 | 1 / 1 |
peripheral blood | 100% | 12589.99 | 925 / 929 | 0% | 0 | 0 / 0 |
heart | 98% | 6240.08 | 841 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 103.65 | 28 / 29 |
muscle | 96% | 3243.32 | 772 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0030968 | Biological process | endoplasmic reticulum unfolded protein response |
GO_1904153 | Biological process | negative regulation of retrograde protein transport, ER to cytosol |
GO_0016567 | Biological process | protein ubiquitination |
GO_0006511 | Biological process | ubiquitin-dependent protein catabolic process |
GO_0030970 | Biological process | retrograde protein transport, ER to cytosol |
GO_0006621 | Biological process | protein retention in ER lumen |
GO_0006605 | Biological process | protein targeting |
GO_0036503 | Biological process | ERAD pathway |
GO_0034976 | Biological process | response to endoplasmic reticulum stress |
GO_0005788 | Cellular component | endoplasmic reticulum lumen |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0000836 | Cellular component | Hrd1p ubiquitin ligase complex |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0002020 | Molecular function | protease binding |
GO_0030246 | Molecular function | carbohydrate binding |
GO_0005515 | Molecular function | protein binding |
Gene name | OS9 |
Protein name | Endoplasmic reticulum lectin (Protein OS-9) Protein OS-9 (Amplified in osteosarcoma 9) Endoplasmic reticulum lectin OS9 endoplasmic reticulum lectin |
Synonyms | |
Description | FUNCTION: Lectin which functions in endoplasmic reticulum (ER) quality control and ER-associated degradation (ERAD). May bind terminally misfolded non-glycosylated proteins as well as improperly folded glycoproteins, retain them in the ER, and possibly transfer them to the ubiquitination machinery and promote their degradation. Possible targets include TRPV4. . FUNCTION: Lectin involved in the quality control of the secretory pathway. As a member of the endoplasmic reticulum-associated degradation lumenal (ERAD-L) surveillance system, targets misfolded endoplasmic reticulum lumenal glycoproteins for degradation. . FUNCTION: Lectin involved in the quality control of the secretory pathway. As a member of the endoplasmic reticulum-associated degradation lumenal (ERAD-L) surveillance system, targets misfolded endoplasmic reticulum lumenal glycoproteins for degradation. . FUNCTION: Lectin involved in the quality control of the secretory pathway. As a member of the endoplasmic reticulum-associated degradation lumenal (ERAD-L) surveillance system, targets misfolded endoplasmic reticulum lumenal glycoproteins for degradation. . FUNCTION: Lectin involved in the quality control of the secretory pathway. As a member of the endoplasmic reticulum-associated degradation lumenal (ERAD-L) surveillance system, targets misfolded endoplasmic reticulum lumenal glycoproteins for degradation. . FUNCTION: Lectin involved in the quality control of the secretory pathway. As a member of the endoplasmic reticulum-associated degradation lumenal (ERAD-L) surveillance system, targets misfolded endoplasmic reticulum lumenal glycoproteins for degradation. . FUNCTION: Lectin involved in the quality control of the secretory pathway. As a member of the endoplasmic reticulum-associated degradation lumenal (ERAD-L) surveillance system, targets misfolded endoplasmic reticulum lumenal glycoproteins for degradation. . FUNCTION: Lectin involved in the quality control of the secretory pathway. As a member of the endoplasmic reticulum-associated degradation lumenal (ERAD-L) surveillance system, targets misfolded endoplasmic reticulum lumenal glycoproteins for degradation. . FUNCTION: Lectin involved in the quality control of the secretory pathway. As a member of the endoplasmic reticulum-associated degradation lumenal (ERAD-L) surveillance system, targets misfolded endoplasmic reticulum lumenal glycoproteins for degradation. . FUNCTION: Lectin involved in the quality control of the secretory pathway. As a member of the endoplasmic reticulum-associated degradation lumenal (ERAD-L) surveillance system, targets misfolded endoplasmic reticulum lumenal glycoproteins for degradation. . FUNCTION: Lectin involved in the quality control of the secretory pathway. As a member of the endoplasmic reticulum-associated degradation lumenal (ERAD-L) surveillance system, targets misfolded endoplasmic reticulum lumenal glycoproteins for degradation. . FUNCTION: Lectin involved in the quality control of the secretory pathway. As a member of the endoplasmic reticulum-associated degradation lumenal (ERAD-L) surveillance system, targets misfolded endoplasmic reticulum lumenal glycoproteins for degradation. . FUNCTION: Lectin involved in the quality control of the secretory pathway. As a member of the endoplasmic reticulum-associated degradation lumenal (ERAD-L) surveillance system, targets misfolded endoplasmic reticulum lumenal glycoproteins for degradation. . FUNCTION: Lectin involved in the quality control of the secretory pathway. As a member of the endoplasmic reticulum-associated degradation lumenal (ERAD-L) surveillance system, targets misfolded endoplasmic reticulum lumenal glycoproteins for degradation. . FUNCTION: Lectin involved in the quality control of the secretory pathway. As a member of the endoplasmic reticulum-associated degradation lumenal (ERAD-L) surveillance system, targets misfolded endoplasmic reticulum lumenal glycoproteins for degradation. . FUNCTION: Lectin involved in the quality control of the secretory pathway. As a member of the endoplasmic reticulum-associated degradation lumenal (ERAD-L) surveillance system, targets misfolded endoplasmic reticulum lumenal glycoproteins for degradation. . FUNCTION: Lectin involved in the quality control of the secretory pathway. As a member of the endoplasmic reticulum-associated degradation lumenal (ERAD-L) surveillance system, targets misfolded endoplasmic reticulum lumenal glycoproteins for degradation. . FUNCTION: Lectin involved in the quality control of the secretory pathway. As a member of the endoplasmic reticulum-associated degradation lumenal (ERAD-L) surveillance system, targets misfolded endoplasmic reticulum lumenal glycoproteins for degradation. . |
Accessions | A0A8V8TPZ9 ENST00000257966.13 [Q13438-7] A0A8V8TQI4 ENST00000700664.1 A0A8V8TQ04 ENST00000315970.12 [Q13438-1] A0A8V8TRE0 A0A8V8TR31 ENST00000389146.11 [Q13438-4] ENST00000551035.5 [Q13438-5] ENST00000700665.1 F8W1V2 ENST00000700661.1 A0A8V8TQI8 Q9BR60 ENST00000389142.10 [Q13438-3] ENST00000550848.5 A0A8V8TQI9 A0A8V8TRD7 ENST00000700660.1 ENST00000700670.1 ENST00000700656.1 F8W1N0 F8VZI7 F8VWQ2 A0A8V8TQI2 ENST00000551285.5 ENST00000700667.1 ENST00000552787.5 ENST00000435406.6 [Q13438-6] A0A8V8TR34 ENST00000700658.1 B4E321 ENST00000550372.5 A0A8V8TQI0 ENST00000547079.5 ENST00000700662.1 ENST00000700663.1 A0A8V8TPZ4 ENST00000700659.1 ENST00000700668.1 Q13438 ENST00000700657.1 A0A8V8TR37 ENST00000552285.6 [Q13438-2] F8W0R2 ENST00000413095.6 ENST00000552423.2 ENST00000439210.6 [Q13438-8] |